V

Vanibhushan

Active Director Director DIN 09594674
DIN 09594674 First appointment May 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value •••• Premium profile

About Vanibhushan

Data last updated:

Vanibhushan is a Director at Mebita Pharmaceutical Private Limited (since 2022). The company operates in Pharma. Mebita Pharmaceutical Private Limited reported revenue of ₹7.91 Cr (FY 2025).

DIN 09594674
Primary Designation Director
Industry Pharma
First Appointment 04 May 2022
Oldest Company Age 7 yrs
Largest company Mebita Pharmaceutical Private Limited · ₹7.91 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 May 20222019₹7.91 Cr (FY 2025)Active

Directorship timeline

Open interactive timeline →
Mebita Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Vanibhushan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vanibhushan

Vanibhushan currently holds 1 directorship: Mebita Pharmaceutical Private Limited (Director, since 04 May 2022, revenue ₹7.91 Cr (FY 2025)).

Vanibhushan was first appointed on 04 May 2022 as Director at Mebita Pharmaceutical Private Limited.

The current boards of Vanibhushan's companies include Abhimanyu Kumar (Mebita Pharmaceutical Private Limited), Narendra Nath Thakur (Mebita Pharmaceutical Private Limited), Nikhil Ranjan (Mebita Pharmaceutical Private Limited), Rupesh Kumar (Mebita Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available